Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of antiparasitic and antifungal agents. Its structure supports the creation of bioactive molecules due to the presence of reactive bromo and trifluoromethyl groups. Commonly employed in medicinal chemistry for scaffold modification in drug discovery programs. Also utilized in the preparation of kinase inhibitors and other targeted therapies in oncology research. Suitable for use in cross-coupling reactions to build complex heterocyclic systems.